HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoon Hee Choi Selected Research

Irinotecan (Camptosar)

1/2012A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activity.
10/2011A phase I study of combination therapy with S-1 and irinotecan in patients with previously untreated metastatic or recurrent colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoon Hee Choi Research Topics

Disease

8Neoplasms (Cancer)
04/2024 - 06/2010
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022 - 04/2010
4Disease Progression
04/2019 - 11/2012
3Adenoid Cystic Carcinoma (Cylindroma)
04/2024 - 10/2021
3Out-of-Hospital Cardiac Arrest
12/2020 - 01/2020
3Heart Arrest (Cardiac Arrest)
06/2020 - 01/2019
3Stomach Neoplasms (Stomach Cancer)
10/2013 - 02/2012
2Pain (Aches)
03/2024 - 01/2023
2Urinary Tract Infections (Urinary Tract Infection)
09/2023 - 02/2023
2Acute Kidney Injury (Acute Renal Failure)
01/2020 - 01/2020
2Poisoning
01/2020 - 07/2014
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 08/2007
2Adenocarcinoma
01/2016 - 10/2013
2Colorectal Neoplasms (Colorectal Cancer)
01/2012 - 10/2011
1Calculi (Calculus)
03/2024
1Ureteral Calculi
03/2024
1Hemorrhage
08/2023
1Wounds and Injuries (Trauma)
02/2023
1Foreign Bodies (Foreign Body)
01/2023
1Deglutition Disorders (Dysphagia)
01/2023
1Fatigue
10/2021
1Stomatitis
10/2021
1Lung Neoplasms (Lung Cancer)
08/2021
1Post-Cardiac Arrest Syndrome
12/2020
1Hyperglycemia
01/2019
1Rhabdomyolysis
07/2018
1Graves Ophthalmopathy
11/2017
1Muscle Weakness
06/2017
1Hematoma
10/2014
1Myocardial Infarction
10/2014
1Obesity
07/2014
1Neoplasm Metastasis (Metastasis)
03/2014
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2014
1Neutropenia
10/2013
1False Aneurysm (Pseudoaneurysm)
01/2012
1Postpartum Hemorrhage
01/2012
1Rupture
01/2012

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
04/2019 - 02/2012
3Pemetrexed (MTA)FDA Link
04/2019 - 04/2010
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 11/2012
2Tyrosine Kinase InhibitorsIBA
04/2024 - 04/2019
2Axitinib (AG 013736)IBA
12/2023 - 10/2021
2PlatinumIBA
02/2023 - 08/2021
2osimertinibIBA
07/2022 - 10/2020
2ErbB Receptors (EGF Receptor)IBA
10/2020 - 04/2019
2Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 10/2011
2Leucovorin (Folinic Acid)FDA Link
01/2016 - 10/2011
2Docetaxel (Taxotere)FDA Link
10/2013 - 11/2012
2Irinotecan (Camptosar)FDA LinkGeneric
01/2012 - 10/2011
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2024
1Analgesics (Analgesic Drugs)IBA
03/2024
1Biomarkers (Surrogate Marker)IBA
12/2023
1Lactic Acid (Lactate)FDA LinkGeneric
08/2023
1Anti-Bacterial Agents (Antibiotics)IBA
02/2023
1palbociclibIBA
02/2023
1C-Reactive ProteinIBA
01/2023
1SodiumIBA
01/2023
1AfatinibIBA
07/2022
1pembrolizumabIBA
08/2021
1AntibodiesIBA
08/2021
1Immune Checkpoint InhibitorsIBA
08/2021
1NivolumabIBA
08/2021
1LigandsIBA
08/2021
1ElementsIBA
12/2020
1Antidepressive Agents (Antidepressants)IBA
01/2020
1Lipocalin-2IBA
01/2020
1Pharmaceutical Sleep AidsIBA
01/2020
1Sitagliptin Phosphate (Januvia)FDA Link
01/2019
1CarbohydratesIBA
01/2019
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2019
1AcarboseFDA LinkGeneric
01/2019
1Metformin (Glucophage)FDA LinkGeneric
01/2019
1DoxylamineIBA
07/2018
1Troleandomycin (TAO)FDA Link
11/2017
1Heparin (Liquaemin)FDA LinkGeneric
10/2014
1CarbamatesIBA
07/2014
1OrganophosphatesIBA
07/2014
1Messenger RNA (mRNA)IBA
03/2014
1dimethyl sulfone (methylsulfonylmethane)IBA
03/2014
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
03/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2014
1titanium silicide (TS-1)IBA
10/2013
1Capecitabine (Xeloda)FDA Link
02/2012
1Sorafenib (BAY 43-9006)FDA Link
02/2012
1ParaffinIBA
12/2010

Therapy/Procedure

8Therapeutics
04/2024 - 08/2007
5Drug Therapy (Chemotherapy)
07/2022 - 06/2010
5Induced Hypothermia
12/2020 - 01/2019
2Length of Stay
03/2024 - 07/2018
2Resuscitation
02/2023 - 01/2012
2Combination Drug Therapy (Combination Chemotherapy)
02/2023 - 11/2012
2Adjuvant Chemotherapy
10/2013 - 11/2012
1Pain Management
03/2024
1Long-Term Care
09/2023
1Critical Care (Surgical Intensive Care)
12/2020
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2020
1Surgical Decompression
10/2014
1Oral Administration
03/2014
1Neoadjuvant Therapy
10/2013
1Cesarean Section (Caesarean Section)
01/2012